Notice of Opportunity To Comment on Strategies To Improve Patient Safety: Draft Report to Congress for Public Comment and Review by the National Academy of Medicine, 81478-81479 [2020-27589]
Download as PDF
81478
Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Opportunity To Comment on
Strategies To Improve Patient Safety:
Draft Report to Congress for Public
Comment and Review by the National
Academy of Medicine
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of opportunity to
comment.
AGENCY:
As required by the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act), the Secretary
of HHS (the Secretary) is making this
draft report on effective strategies for
reducing medical errors and increasing
patient safety available to the public for
review and comment. The draft report
includes measures determined
appropriate by the Secretary to
encourage the appropriate use of such
strategies.
SUMMARY:
Send comments on or before
February 16, 2021.
ADDRESSES: The draft report, Strategies
to Improve Patient Safety: Draft Report
to Congress for Public Comment and
Review by the National Academy of
Medicine, can be accessed electronically
at the following HHS website: https://
pso.ahrq.gov/legislation/act. Comments
on the draft report must be submitted by
email to PSQIA.RC@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Paula DiStabile, Patient Safety
Organization Division, Center for
Quality Improvement and Patient
Safety, AHRQ, 5600 Fishers Lane,
Mailstop 06N100B, Rockville, MD
20857; telephone (toll free): (866) 403–
3697; telephone (local): (301) 427–1111;
TTY (toll free): (866) 438–7231; TTY
(local): (301) 427–1130; email:
PSQIA.RC@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
DATES:
khammond on DSKJM1Z7X2PROD with NOTICES
Background
The Secretary, in consultation with
the Director of AHRQ, has prepared a
draft report on effective strategies for
reducing medical errors and increasing
patient safety as required by the Patient
Safety Act. The report includes
measures determined appropriate by the
Secretary to encourage the appropriate
use of such strategies, including use in
any federally funded programs. The
draft report is now available for public
comment and will be (or has been)
VerDate Sep<11>2014
17:58 Dec 15, 2020
Jkt 253001
submitted to the National Academy of
Medicine for review. The final report is
required to be submitted to Congress no
later than December 21, 2021. The
specific provision describing these
requirements can be found at 42 U.S.C.
299b–22(j).
The Patient Safety Act created a
framework for the development of a
voluntary patient safety event reporting
system to advance patient safety and
quality of care across the Nation.
Without limiting patients’ rights to their
medical information, the law created
Federal legal privilege and
confidentiality protections for patient
safety work product; that is, information
exchanged between healthcare
providers and organizations listed by
the Secretary that specialize in patient
safety and quality improvement, called
patient safety organizations (PSOs). The
law charged PSOs with analyzing and
using this information to provide
feedback and assistance to help
providers minimize patient risk and
improve the safety and quality of their
care. More information about the Patient
Safety Act, its implementing regulation,
and PSOs can be found at https://
pso.ahrq.gov/.
In addition to creating a protected
legal environment where healthcare
providers can share information and
learning for improvement purposes
beyond organizational and State
boundaries, Congress also envisioned
and created the potential for aggregating
and analyzing patient safety data on a
national scale. This part of the Patient
Safety Act, the network of patient safety
databases (NPSD), is a mechanism that
can leverage data contributed by
individual healthcare providers and
PSOs across the United States into a
valuable national resource for
improving patient safety. Congress
required the draft report that is the
subject of this Notice to be made
available for public comment and
submitted to the Institute of Medicine
(now the National Academy of
Medicine) no later than 18 months after
the NPSD became operational. The
NPSD became operational on June 21,
2019. More information about the NPSD
can be found at https://www.ahrq.gov/
npsd/.
underlying effective patient safety
improvement, provides an overview of
research and measurement in patient
safety, and presents the strategies and
practices for reducing medical errors
and increasing patient safety reviewed
in AHRQ’s Making Healthcare Safer
reports, published in 2001, 2013, and
2020. Together, these reports reviewed
the existing evidence for the
effectiveness of more than 100 patient
safety strategies and practices used in
hospitals, primary care practices, longterm care facilities, and other healthcare
settings. They include cross-cutting
strategies and topics such as patient and
family engagement and teamwork
training; safety topics specific to
particular clinical interventions, such as
medications and surgery; a variety of
tools and processes, such as rapid
response teams and antimicrobial
stewardship; and practices that target
prevention of specific harms, such as
healthcare-associated infections and
pressure injuries. Hyperlinks in the
draft report lead to the full text of the
evidence review and to later updates
regarding the assessment of evidence for
the effectiveness for each strategy and
practice. The final chapter in the draft
report begins with an overview of
learning health systems and concepts
underlying effective implementation of
patient safety strategies. It provides
examples of resources Federal agencies
make available to encourage healthcare
providers to use effective patient safety
strategies and describes ‘‘Safer Together:
A National Action Plan to Advance
Patient Safety,’’ recently released by the
National Steering Committee for Patient
Safety that was convened by the
Institute for Healthcare Improvement.
The draft report concludes by describing
an approach that has a track record of
success in encouraging providers to use
effective practices to improve patient
safety and outlines measures that could
accelerate progress in improving patient
safety and encouraging the use of
effective patient safety improvement
strategies.
Overview of the Draft Report
The draft report is posted on the
AHRQ PSO Program website at https://
pso.ahrq.gov/legislation/act. The
website contains a link to the email
address for submitting comments on the
draft report, which is PSQIA.RC@
ahrq.hhs.gov.
The draft report contains three
chapters. It begins with an overview of
the impetus for and objectives of the
Patient Safety Act, its key provisions,
and some milestones in its
implementation. Chapter 2 reviews
some of the principles and concepts
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Where To View the Draft Report and
How To Submit Comments
E:\FR\FM\16DEN1.SGM
16DEN1
Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices
Dated: December 10, 2020.
Marquita Cullom,
Associate Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2020–27589 Filed 12–15–20; 8:45 am]
BILLING CODE 4160–90–P
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Office of the Secretary
Delegation of Authority
Notice is hereby given that I have
delegated to the National Coordinator
for Health Information Technology,
Office of the National Coordinator for
Health Information Technology (ONC),
or his or her successor, the authorities
that are vested in the Secretary of Health
and Human Services under title III,
Section 307, ‘‘International
Cooperation,’’ of the Public Health
Service (PHS) Act, [42 U.S.C. 242 l], as
amended, with regard to participating
with other countries in cooperative
endeavors.
Limitation
This delegation of authority may be
re-delegated within ONC. Previous
delegations and re-delegations made to
officials within the Department of
Health and Human Services for
authorities under Section 307 of the
PHS Act continue in effect. Exercise of
this authority shall be in accordance
with established policies, procedures,
guidelines, and regulations as
prescribed by the Secretary. The
Secretary retains the authority to submit
reports to Congress, promulgate
regulations, and to establish advisory
committees and councils and appoint
their members. I hereby affirm and ratify
any actions taken by the National
Coordinator, ONC, or other ONC
officials, which involve the exercise of
this authority prior to the effective date
of this delegation.
Effective Date
This delegation of authority is
effective immediately.
khammond on DSKJM1Z7X2PROD with NOTICES
Authority
Section 6 of the Reorganization Plan
No. 1 of 1953 and Section 2 of the
Reorganization Plan No. 3 of 1966.
Dated: December 9, 2020.
Eric D. Hargan,
Deputy Secretary.
[FR Doc. 2020–27606 Filed 12–15–20; 8:45 am]
BILLING CODE 4150–45–P
VerDate Sep<11>2014
17:58 Dec 15, 2020
Jkt 253001
Name of Committee: National Cancer
Institute Special Emphasis Panel; K22
Transition Career Development Award.
Date: January 19, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Rockville, Maryland 20850,
240–276–6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Assay
Validation of High-Quality Markers for
Clinical Studies in Cancer.
Date: January 21, 2021.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W124, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W124, Rockville,
Maryland 20850, 240–276–6342 choe@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Applications related to Pediatrics.
Date: January 26, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
81479
7W530, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W530, Rockville, Maryland 20850,
240–276–6442 ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–3:
SBIR Contract Review.
Date: January 29, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W254, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Rockville, Maryland
20850, 240–276–7975 chufanee@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: February 4–5, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville,
Maryland 20817, 240–672–6175 singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–2: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: February 4–5, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850
(Telephone Conference Call)
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20854, 240–276–7286 salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review IV.
Date: February 9–10, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
E:\FR\FM\16DEN1.SGM
16DEN1
Agencies
[Federal Register Volume 85, Number 242 (Wednesday, December 16, 2020)]
[Notices]
[Pages 81478-81479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27589]
[[Page 81478]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Opportunity To Comment on Strategies To Improve Patient
Safety: Draft Report to Congress for Public Comment and Review by the
National Academy of Medicine
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of opportunity to comment.
-----------------------------------------------------------------------
SUMMARY: As required by the Patient Safety and Quality Improvement Act
of 2005 (Patient Safety Act), the Secretary of HHS (the Secretary) is
making this draft report on effective strategies for reducing medical
errors and increasing patient safety available to the public for review
and comment. The draft report includes measures determined appropriate
by the Secretary to encourage the appropriate use of such strategies.
DATES: Send comments on or before February 16, 2021.
ADDRESSES: The draft report, Strategies to Improve Patient Safety:
Draft Report to Congress for Public Comment and Review by the National
Academy of Medicine, can be accessed electronically at the following
HHS website: https://pso.ahrq.gov/legislation/act. Comments on the
draft report must be submitted by email to [email protected].
FOR FURTHER INFORMATION CONTACT: Paula DiStabile, Patient Safety
Organization Division, Center for Quality Improvement and Patient
Safety, AHRQ, 5600 Fishers Lane, Mailstop 06N100B, Rockville, MD 20857;
telephone (toll free): (866) 403-3697; telephone (local): (301) 427-
1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
email: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The Secretary, in consultation with the Director of AHRQ, has
prepared a draft report on effective strategies for reducing medical
errors and increasing patient safety as required by the Patient Safety
Act. The report includes measures determined appropriate by the
Secretary to encourage the appropriate use of such strategies,
including use in any federally funded programs. The draft report is now
available for public comment and will be (or has been) submitted to the
National Academy of Medicine for review. The final report is required
to be submitted to Congress no later than December 21, 2021. The
specific provision describing these requirements can be found at 42
U.S.C. 299b-22(j).
The Patient Safety Act created a framework for the development of a
voluntary patient safety event reporting system to advance patient
safety and quality of care across the Nation. Without limiting
patients' rights to their medical information, the law created Federal
legal privilege and confidentiality protections for patient safety work
product; that is, information exchanged between healthcare providers
and organizations listed by the Secretary that specialize in patient
safety and quality improvement, called patient safety organizations
(PSOs). The law charged PSOs with analyzing and using this information
to provide feedback and assistance to help providers minimize patient
risk and improve the safety and quality of their care. More information
about the Patient Safety Act, its implementing regulation, and PSOs can
be found at https://pso.ahrq.gov/.
In addition to creating a protected legal environment where
healthcare providers can share information and learning for improvement
purposes beyond organizational and State boundaries, Congress also
envisioned and created the potential for aggregating and analyzing
patient safety data on a national scale. This part of the Patient
Safety Act, the network of patient safety databases (NPSD), is a
mechanism that can leverage data contributed by individual healthcare
providers and PSOs across the United States into a valuable national
resource for improving patient safety. Congress required the draft
report that is the subject of this Notice to be made available for
public comment and submitted to the Institute of Medicine (now the
National Academy of Medicine) no later than 18 months after the NPSD
became operational. The NPSD became operational on June 21, 2019. More
information about the NPSD can be found at https://www.ahrq.gov/npsd/.
Overview of the Draft Report
The draft report contains three chapters. It begins with an
overview of the impetus for and objectives of the Patient Safety Act,
its key provisions, and some milestones in its implementation. Chapter
2 reviews some of the principles and concepts underlying effective
patient safety improvement, provides an overview of research and
measurement in patient safety, and presents the strategies and
practices for reducing medical errors and increasing patient safety
reviewed in AHRQ's Making Healthcare Safer reports, published in 2001,
2013, and 2020. Together, these reports reviewed the existing evidence
for the effectiveness of more than 100 patient safety strategies and
practices used in hospitals, primary care practices, long-term care
facilities, and other healthcare settings. They include cross-cutting
strategies and topics such as patient and family engagement and
teamwork training; safety topics specific to particular clinical
interventions, such as medications and surgery; a variety of tools and
processes, such as rapid response teams and antimicrobial stewardship;
and practices that target prevention of specific harms, such as
healthcare-associated infections and pressure injuries. Hyperlinks in
the draft report lead to the full text of the evidence review and to
later updates regarding the assessment of evidence for the
effectiveness for each strategy and practice. The final chapter in the
draft report begins with an overview of learning health systems and
concepts underlying effective implementation of patient safety
strategies. It provides examples of resources Federal agencies make
available to encourage healthcare providers to use effective patient
safety strategies and describes ``Safer Together: A National Action
Plan to Advance Patient Safety,'' recently released by the National
Steering Committee for Patient Safety that was convened by the
Institute for Healthcare Improvement. The draft report concludes by
describing an approach that has a track record of success in
encouraging providers to use effective practices to improve patient
safety and outlines measures that could accelerate progress in
improving patient safety and encouraging the use of effective patient
safety improvement strategies.
Where To View the Draft Report and How To Submit Comments
The draft report is posted on the AHRQ PSO Program website at
https://pso.ahrq.gov/legislation/act. The website contains a link to
the email address for submitting comments on the draft report, which is
[email protected].
[[Page 81479]]
Dated: December 10, 2020.
Marquita Cullom,
Associate Director.
[FR Doc. 2020-27589 Filed 12-15-20; 8:45 am]
BILLING CODE 4160-90-P